June 25, 2020 / 11:31 AM / 2 months ago

LabCorp launches new neutralizing antibody test for COVID-19

(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus.

Information from the test about the virus-fighting ability of antibodies could be used in the development of COVID-19 vaccines, the company said.

The test, called the neutralizing antibody test, would be available to biopharmaceutical companies, hospitals, blood banks and other blood plasma-screening facilities.

Neutralizing antibodies are associated with protective immunity against re-infection for many infectious pathogens, according to the Mayo Clinic.

The test could be used in screening serum collected from recovered COVID-19 patients for preventive and therapeutic use, the company said.

The company made its COVID-19 tests available at workplaces last month and it also provides lab tests and antibody blood tests that can tell whether a person has ever been infected, as well as kits that allow people to mail in their own nasal swab samples collected at home.

Reporting by Manojna Maddipatla in Bengaluru; Editing by Aditya Soni

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below